Skip to main content

Contineum Therapeutics, Inc.

CTNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001855175

In the last 90 days, Contineum Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $500.6M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.

Q2 2025 vs. Q1 2025

How the institutions holding Contineum Therapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of CTNM: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders6370+7
Shares15.3M13.9M−1.41M (−9.2%)
Value$106.7M$55.4M−$51.3M (−48.1%)

New holders (27)

Institutions that held Contineum Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to CTNM in Q2 2025
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.388,639$1.54M0.00%
Millennium Management LLC132,378$525.5K0.00%
Monaco Asset Management SAM75,000$297.8K0.11%
Two Sigma Investments, LP60,963$242.0K0.00%
Two Sigma Advisers, LP43,200$171.5K0.00%
RBF Capital, LLC40,000$158.8K0.01%
Y-Intercept (Hong Kong) Ltd35,156$139.6K0.00%
Independent Financial Group, LLC27,021$107.3K0.00%
AQR Capital Management LLC25,156$99.9K0.00%
Jane Street Group, LLC20,321$80.7K0.00%
Jain Global LLC19,590$77.8K0.00%
Bridgeway Capital Management, LLC19,200$76.2K0.00%
Jacobs Levy Equity Management, Inc17,245$68.5K0.00%
Citadel Advisors LLC16,489$65.5K0.00%
Renaissance Technologies LLC14,404$57.2K0.00%
Prelude Capital Management, LLC13,920$55.3K0.01%
Marex Group plc11,400$45.3K0.00%
Qube Research & Technologies Ltd10,924$43.4K0.00%
Acadian Asset Management LLC5,400$21.0K0.00%
Point72 Asia (Singapore) Pte. Ltd.4,844$19.2K0.00%
Federation des caisses Desjardins du Quebec2,560$10.2K0.00%
True Wealth Design, LLC124$4930.00%
Point72 (DIFC) Ltd65$2580.00%
Clearstead Advisors, LLC33$1320.00%
Cubist Systematic Strategies, LLC24$950.00%
Advisor Group Holdings, Inc.10$700.00%
IFP Advisors, Inc1$40.00%

Sold out (20)

Institutions that held Contineum Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.